A Phase I and Pharmacokinetic Study of the Oral Histone Deacetylase Inhibitor, MS-275, in Patients with Refractory Solid Tumors and Lymphomas
暂无分享,去创建一个
M. Rothenberg | A. Sandler | A. Schott | S. Eckhardt | L. Gore | C. O’Bryant | C. McCoy | M. Schultz | D. Coffin | C. Scholz | Alan B. Sandler